ProfileGDS4718 / 225148_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 86% 85% 87% 87% 84% 88% 88% 87% 84% 86% 86% 88% 87% 88% 87% 86% 84% 88% 88% 90% 88% 86% 86% 87% 86% 87% 85% 84% 81% 88% 81% 84% 86% 85% 84% 86% 88% 87% 86% 89% 86% 83% 85% 85% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.6940586
GSM549102patient 115, normal, homogenized [OPG study]8.4248885
GSM549104patient 119, normal, homogenized [OPG study]8.8182587
GSM549108patient 138, normal, homogenized [OPG study]8.6752487
GSM549119patient 077, normal, homogenized [OPG study]8.3406584
GSM549133patient 032, cancer, homogenized [OPG study]8.9867688
GSM549139patient 042, cancer, homogenized [OPG study]8.8657388
GSM549099patient 107, normal, homogenized [OPG study]8.6766787
GSM549109patient 139, normal, homogenized [OPG study]8.3074684
GSM549110patient 046, normal, homogenized [OPG study]8.5643786
GSM549114patient 063, normal, homogenized [OPG study]8.784286
GSM549122patient 082, normal, homogenized [OPG study]8.8316588
GSM549134patient 033, cancer, homogenized [OPG study]8.8137487
GSM549136patient 036, cancer, homogenized [OPG study]8.9204988
GSM549140patient 044, cancer, homogenized [OPG study]8.8304487
GSM549111patient 047, normal, homogenized [OPG study]8.6538686
GSM549113patient 057, normal, homogenized [OPG study]8.5437184
GSM549132patient 031, cancer, homogenized [OPG study]8.8631988
GSM549137patient 038, cancer, homogenized [OPG study]8.8424988
GSM549142patient 047, cancer, homogenized [OPG study]8.733490
GSM549100patient 110, normal, homogenized [OPG study]8.8468488
GSM549107patient 135, normal, homogenized [OPG study]8.7179486
GSM549115patient 068, normal, homogenized [OPG study]8.7677386
GSM549116patient 072, normal, homogenized [OPG study]8.828487
GSM549120patient 078, normal, homogenized [OPG study]8.6760486
GSM549131patient 030, cancer, homogenized [OPG study]8.8827887
GSM549118patient 074, normal, homogenized [OPG study]8.447785
GSM549129patient 027, cancer, homogenized [OPG study]8.3144884
GSM549123patient 088, normal, homogenized [OPG study]8.0091681
GSM549124patient 006, cancer, homogenized [OPG study]8.6744388
GSM549126patient 015, cancer, homogenized [OPG study]7.9268281
GSM549128patient 025, cancer, homogenized [OPG study]8.4178984
GSM549103patient 117, normal, homogenized [OPG study]8.4566286
GSM549117patient 073, normal, homogenized [OPG study]8.632585
GSM549138patient 041, cancer, homogenized [OPG study]8.4183784
GSM549141patient 045, cancer, homogenized [OPG study]8.7252686
GSM549130patient 028, cancer, homogenized [OPG study]8.7696288
GSM549101patient 111, normal, homogenized [OPG study]8.6222887
GSM549105patient 128, normal, homogenized [OPG study]8.5542386
GSM549106patient 134, normal, homogenized [OPG study]9.1149289
GSM549112patient 048, normal, homogenized [OPG study]8.6346986
GSM549125patient 011, cancer, homogenized [OPG study]8.1724283
GSM549127patient 024, cancer, homogenized [OPG study]8.4593385
GSM549135patient 035, cancer, homogenized [OPG study]8.5218185